RBC Capital lowered the firm’s price target on Pharming (PHAR) to EUR 1.60 from EUR 1.65 and keeps an Outperform rating on the shares.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter